We are live on ! Find out more

GNMK

GenMark Diagnostics, Inc

GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

86 hedge funds and large institutions have $618M invested in GenMark Diagnostics, Inc in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New

Increased

Maintained

Reduced

Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

7% more capital invested

Capital invested by funds: $577M → $618M (+$40.6M)

4% less funds holding

Funds holding: 90 → 86 (-4)

Holders

Holders Change

-4

Holders Change %

-4.44%

% of All Funds

2.14%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+100%

% of All Funds

0.05%

New

Increased

Reduced

Closed

Calls

$66K

Puts

–

Net Calls

+$66K

Net Calls Change

-$123K

Top Buyers

Rank	Fund	Capital Flow
1	BlackRock New York	+$35.7M
2	GTC Ghost Tree Capital New York	+$7.82M
3	Citadel Advisors Miami, Florida	+$4.85M
4	SSA Schonfeld Strategic Advisors New York	+$3.91M
5	BG Bellevue Group Kuesnacht, Switzerland	+$3.76M

Top Sellers

Rank	Fund	Capital Flow
1	Morgan Stanley New York	-$12.4M
2	Adage Capital Partners Boston, Massachusetts	-$2.41M
3	Jennison Associates New York	-$1.49M
4	AIM Artemis Investment Management Edinburgh, United Kingdom	-$1.33M
5	CC Casdin Capital New York	-$1.32M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	BG 26 Bellevue Group Kuesnacht, Switzerland	$4.01M	+$3.76M	+312,666	New
27	27 Allianz Asset Management Munich, Germany	$3.23M	+$85.1K	+7,074	+3%
28	28 Charles Schwab San Francisco, California	$3.03M	+$685K	+56,876	+32%
29	29 Bank of New York Mellon New York	$2.63M	+$78K	+6,482	+3%
30	30 D.E. Shaw & Co New York	$2.47M	+$2.19M	+182,324	+1,785%
31	31 Deutsche Bank Frankfurt Am Main Ge, Germany	$2.28M	+$1.09M	+90,519	+103%
32	32 Alyeska Investment Group Chicago, Illinois	$2.27M	-$25.1K	-2,088	-1%
33	TCIM 33 TIAA CREF Investment Management New York	$2.15M	-$95K	-7,896	-4%
34	TA 34 Teachers Advisors New York	$1.42M	+$155K	+12,864	+13%
35	35 TD Asset Management Toronto, Ontario, Canada	$1.31M	+$37K	+3,074	+3%
36	36 Two Sigma Investments New York	$1.25M	+$324K	+26,899	+38%
37	TCM 37 Tekla Capital Management Boston, Massachusetts	$1.2M	–	–	–
38	38 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$1.1M	-$48.1K	-4,000	-4%
39	WMSA 39 Weiss Multi-Strategy Advisers New York	$897K	–	–	–
40	DCM 40 Donaldson Capital Management Evansville, Indiana	$852K	+$36	+3	+0%
41	41 Goldman Sachs New York	$846K	+$669K	+55,546	+530%
42	42 Swiss National Bank Zurich, Switzerland	$831K	–	–	–
43	43 AllianceBernstein Nashville, Tennessee	$681K	-$36.1K	-3,000	-5%
44	44 California Public Employees Retirement System Sacramento, California	$650K	-$26.5K	-2,200	-4%
45	45 RhumbLine Advisers Boston, Massachusetts	$616K	+$27.9K	+2,321	+5%
46	46 Baird Financial Group Milwaukee, Wisconsin	$595K	–	–	–
47	47 Wells Fargo San Francisco, California	$574K	-$23.8K	-1,974	-4%
48	48 Two Sigma Advisers New York	$536K	-$16.9K	-1,400	-3%
49	GCP 49 GSA Capital Partners London, United Kingdom	$452K	+$425K	+35,290	New
50	50 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$444K	+$57.3K	+4,757	+16%

GNMK Hedge Fund Activity: Q1 2017 in Review

86 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2017, worth a combined $618M — up 7% from $577M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $35.7M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.

86 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2017, down from 90 in Q4 2016.
Funds reported $618M of GenMark Diagnostics, Inc stock for Q1 2017, up 7% quarter-over-quarter.
10 funds opened new GenMark Diagnostics, Inc positions in Q1 2017 and 9 closed out, a net change of +1 holder.
The largest GenMark Diagnostics, Inc buyer in Q1 2017 was BlackRock, an estimated $35.7M added.
The largest GenMark Diagnostics, Inc seller in Q1 2017 was Morgan Stanley, an estimated $12.4M sold.

Based on aggregated 13F filings for Q1 2017.

GenMark Diagnostics, Inc GNMK